Vir Biotechnology Inc (VIR)
Healthcare
Biotechnology
8.70 $
-2.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Vir Biotechnology Inc (VIR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -132 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -389 | -156 | -108 | -109 | -78 | -171 | -88 | -78 | -120 | -168 | -26 | -132 | -446 | |
| 7.0 | 6.4 | 4.5 | 4.5 | 4.3 | 2.9 | 2.9 | 2.9 | 9.5 | 3.0 | 2.9 | 2.8 | 18 | |
| 31 | 27 | 28 | 24 | 22 | 17 | 16 | 14 | 12 | 11 | 23 | 12 | 58 | |
| 48 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -253 | -30 | -33 | -82 | -2.4 | 17 | -17 | 26 | -25 | -21 | -2.8 | -23 | -71 | |
| 9.5 | 3.7 | 1.5 | 1.9 | 0.7 | 2.4 | 2.4 | 1.6 | 2.5 | 0.3 | 4.5 | 0.4 | 7.7 | |
| 230 | -59 | -105 | 28 | 212 | 119 | 141 | 127 | 56 | 40 | 87 | 12 | 195 | |
| 3.2 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 0.0 | – | 0.0 | – | – | – | – | – | |
| 3.2 | 0.3 | 1.7 | 0.2 | 2.9 | 0.0 | 1.3 | 0.6 | 2.0 | 0.1 | 1.0 | 163 | 166 | |
| -156 | -215 | -210 | -81 | 137 | -53 | 54 | 49 | -62 | -127 | 62 | 42 | -85 | |
| -399 | -160 | -109 | -111 | -79 | -174 | -90 | -80 | -123 | -168 | -21 | -133 | -445 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.